Airija - anglų - HPRA (Health Products Regulatory Authority)

clonmel healthcare ltd - fluvastatin sodium - tablet prolonged release - 80 milligram

Airija - anglų - HPRA (Health Products Regulatory Authority)

actavis group ptc ehf - fluvastatin sodium - capsules hard - 20 milligram

Airija - anglų - HPRA (Health Products Regulatory Authority)

actavis group ptc ehf - fluvastatin sodium - capsules hard - 40 milligram

Airija - anglų - HPRA (Health Products Regulatory Authority)

actavis group ptc ehf - fluvastatin sodium - tablet prolonged release - 80 milligram

Airija - anglų - HPRA (Health Products Regulatory Authority)

mcdermott laboratories ltd t/a gerard laboratories - fluvastatin - capsules hard - 20 milligram

Airija - anglų - HPRA (Health Products Regulatory Authority)

mcdermott laboratories ltd t/a gerard laboratories - fluvastatin - capsules hard - 40 milligram

Airija - anglų - HPRA (Health Products Regulatory Authority)

mcdermott laboratories ltd t/a gerard laboratories - fluvastatin sodium - tablet prolonged release - 80 milligram

Australija - anglų - Department of Health (Therapeutic Goods Administration)

novartis pharmaceuticals australia pty ltd - fluvastatin sodium -

Australija - anglų - Department of Health (Therapeutic Goods Administration)

novartis pharmaceuticals australia pty ltd - fluvastatin sodium -

Izraelis - anglų - Ministry of Health

taro pharmaceutical industries ltd - warfarin sodium - tablets - warfarin sodium 1 mg - warfarin - warfarin - coumadin is indicated for the prophylaxis and/or treatment of venous thrombosis and its extension, and pulmonary embolism. coumadin is indicated for the prophylaxis and/or treatment of the thromboembolic complications associated with atrial fibrillation and/or cardiac valve replacement. coumadin is indicated to reduce the risk of death, recurrent myocardial infarction, and thromboembolic events such as stroke or systemic embolization after myocardial infarction.